The United States Patent and Trademark Office (USPTO) has published a patent application, US20260085359A1, filed by TORAY INDUSTRIES, INC. The application details a novel kit, device, and method for detecting breast cancer. The core of the invention lies in the use of specific nucleic acids designed to bind to a miRNA present in a biological sample, enabling in vitro detection of the cancer.

This publication represents a new patent application and does not impose immediate regulatory obligations. However, it signifies potential future intellectual property in the field of cancer diagnostics. Companies involved in developing or manufacturing diagnostic kits, medical devices, or pharmaceutical products related to breast cancer detection should be aware of this filing as it may impact future product development, licensing, or competitive landscape.